3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
20
Prostatic Neoplasms
11
Neoplasm Metastasis
9
Melanoma
8
Lung Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Kidney Neoplasms
7
Sarcoma
6
Liver Neoplasms
6
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Desmoid Tumors
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pain
2
Keratosis, Actinic
2
Esophageal Neoplasms
2
Disease
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Wilms Tumor
1
Uveal Melanoma
1
Interventions
Cyclophosphamide
3
fludarabine
2
Radiotherapy
2
Interleukin-2
2
tislelizumab
1
pembrolizumab
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
niraparib
1
neotil
1
lenvatinib
1
atezolizumab
1
Yoga
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Tiragolumab
1
Surveys and Questionnaires
1
Radiation
1
Positron-Emission Tomography
1
Nivolumab
1
Magnetic Resonance Imaging
1
Lacteol
1
Ipilimumab
1
High-Throughput Nucleotide Sequencing
1
Fluorodeoxyglucose F18
1
Data Collection
1
Cryosurgery
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solid Tumor, Adult
×
Cryosurgery
×
Clear all
NCT06032845
2025-02-27
CASTLE-11
Fudan University
Phase 2
Recruiting
25 enrolled